Tonix Pharmaceuticals Hol... (TNXP)
NASDAQ: TNXP
· Real-Time Price · USD
51.66
-7.92 (-13.29%)
At close: Aug 15, 2025, 1:03 PM
Tonix Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.83M | 10.04M | 10.09M | -22.61M | -21.44M | -23.65M | 7.77M | 37.89M | 33.9M | 42.93M | 9.03M | 9.03M | 9.03M | n/a | n/a | 2.91M | 2.91M | 2.91M |
Cost of Revenue | 6.95M | 7.05M | 7.76M | -20.95M | -20.13M | 5.51M | 4.74M | 33.1M | 30.73M | 1.83M | 1M | 192K | 18.73M | 42.19M | 62.86M | 62.83M | 56.3M | 46.93M |
Gross Profit | 2.88M | 2.99M | 2.33M | -1.67M | -1.32M | -29.16M | 3.03M | 4.79M | 3.17M | 41.1M | 8.03M | 8.84M | -9.7M | -42.19M | -62.86M | -59.92M | -53.38M | -44.01M |
Operating Income | -82.38M | -72.45M | -77.74M | -82.59M | -95.19M | -105.83M | -118.38M | -123.78M | -125.22M | -119.56M | -112.05M | -108.89M | -97.83M | -98.06M | -92.39M | -79.86M | -73.32M | -63.95M |
Interest Income | 943K | n/a | n/a | -1.72M | -1.54M | -897K | n/a | 2.76M | 3.2M | 2.75M | 1.87M | 832K | 229K | 42K | 106K | 101K | 103K | 107K |
Pretax Income | -81.42M | -131.93M | -130.04M | -135.25M | -149.01M | -98.59M | -116.66M | -121.02M | -122.02M | -116.81M | -110.22M | -108.09M | -97.64M | -98.05M | -92.29M | -79.75M | -73.22M | -63.84M |
Net Income | -53.15M | -131.93M | -130.04M | -135.25M | -149.01M | -98.59M | -116.66M | -123.42M | -124.43M | -123.47M | -116.88M | -112.35M | -101.89M | -98.05M | -92.29M | -79.75M | -73.22M | -63.84M |
Selling & General & Admin | 49.59M | 40.9M | 40.1M | 36.14M | 37.15M | 36.67M | 34.75M | 31.18M | 29.86M | 29.59M | 30.21M | 29.43M | 27.49M | 26.16M | 23.55M | 21.22M | 18.95M | 17.14M |
Research & Development | 35.67M | 34.55M | 39.97M | 48.79M | 60.73M | 73.01M | 86.66M | 94.21M | 95.36M | 89.97M | 81.88M | 79.5M | 70.38M | 71.93M | 68.84M | 58.64M | 54.37M | 46.81M |
Other Expenses | n/a | n/a | n/a | -1.54M | -1.54M | -897K | n/a | 1.54M | 1.54M | 897K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 85.26M | 75.44M | 80.07M | 84.94M | 97.88M | 109.68M | 121.41M | 125.39M | 125.22M | 119.56M | 112.09M | 108.92M | 97.87M | 98.09M | 92.39M | 79.86M | 73.32M | 63.95M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 12.18M | 12.18M | 12.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 92.22M | 82.49M | 87.84M | 93.88M | 107.64M | 116.08M | 126.15M | 127.77M | 125.22M | 119.56M | 112.09M | 108.92M | 97.87M | 98.09M | 92.39M | 79.86M | 73.32M | 63.95M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.61M | 5.61M | 5.42M | 5.4M | -215K | -215K | -19K | -0.00 | -7K | -7K | -7K |
Shares Outstanding (Basic) | 7.33M | 5.93M | 2.26M | 6.21M | 4.09M | 2.53M | 1.83M | 7.24M | 5.76M | 3.21M | 3.07M | 2.14M | 1.12M | 8.16M | 7.05M | 5.79M | 5.24M | 4.53M |
Shares Outstanding (Diluted) | 7.33M | 5.93M | 2.26M | 6.21M | 4.09M | 2.53M | 1.83M | 7.24M | 5.76M | 3.21M | 3.07M | 2.14M | 1.12M | 8.16M | 7.05M | 5.79M | 5.24M | 4.53M |
EPS (Basic) | -16.7 | -1.94K | -2.51K | -8.68K | -8.72K | -6.84K | -6.37K | -302.58 | -399.63 | -594.4 | -811.68 | -1.15K | -1.33K | -1.54K | -1.67K | -1.86K | -2.11K | -3.14K |
EPS (Diluted) | -16.7 | -1.94K | -2.51K | -8.68K | -8.72K | -6.84K | -6.37K | -302.58 | -399.63 | -594.4 | -811.68 | -1.15K | -1.33K | -1.54K | -1.67K | -1.86K | -2.11K | -3.14K |
EBITDA | -81.01M | -70.1M | -74.43M | -78.82M | -90.77M | -101.46M | -114.09M | -119.98M | -122.32M | -117.47M | -110.84M | -108.4M | -97.58M | -97.91M | -92.26M | -79.83M | -73.29M | -63.92M |
EBIT | -81.42M | -71.51M | -76.03M | -81.25M | -95.19M | -105.83M | -118.38M | -123.78M | -125.22M | -119.56M | -112.09M | -108.84M | -97.79M | -98.01M | -92.31M | -79.86M | -73.32M | -63.95M |
Depreciation & Amortization | 1.5M | 2.7M | 3.42M | 4.45M | 4.91M | 4.61M | 4.29M | 3.61M | 2.88M | 2.08M | 1.25M | 444K | 202K | 107K | 50K | 30K | 28K | 27K |